(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.